— Know what they know.
Not Investment Advice
Also trades as: H02.SI (SES) · $vol 3M · HAWPY (OTC) · $vol 0M

HAWPF OTC

Haw Par Corporation Limited
1W: +0.0% 1M: -14.2% 3M: -10.0% YTD: -11.7% 1Y: -3.8% 3Y: +75.9% 5Y: +38.1%
$10.80
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 37 · $2.4B mcap · 138M float · 0.0000% daily turnover · Short 90% of daily vol

Income Trends

Revenue
$230M -6.1% ▼
5Y CAGR: +15.7%
Gross Profit
$129M -4.0% ▼
5Y CAGR: +21.4%
Operating Income
$67M +5.0% ▲
5Y CAGR: +36.9%
Net Income
$265M +16.2% ▲
5Y CAGR: +17.2%
EPS (Diluted)
$1.20 +16.5% ▲
5Y CAGR: +17.3%
EBITDA
$73M -71.1% ▼
5Y CAGR: +29.1%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$141M$182M$232M$245M$230M
YoY Growth+27.2%+29.0%+27.4%+5.5%-6.1%
Cost of Revenue$68M$84M$97M$111M$101M
Gross Profit$74M$99M$135M$134M$129M
Gross Margin52.2%54.1%58.1%54.8%56.0%
R&D Expenses$0$0$0$0$0
SG&A Expenses$49M$55M$71M$70M$62M
Operating Expenses$49M$55M$71M$134M$62M
Operating Income$25M$43M$64M$64M$67M
Operating Margin17.5%23.8%27.6%26.1%29.2%
Interest Expense$0$0$2M$2M$2M
Income Before Tax$116M$159M$229M$246M$281M
Tax Expense$6M$11M$13M$18M$16M
Net Income$110M$148M$217M$228M$265M
Net Margin78.0%81.5%93.3%93.2%115.4%
EPS (Diluted)$0.50$0.67$0.98$1.03$1.20
EBITDA$31M$49M$70M$254M$73M
Shares Outstanding221M221M221M221M221M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms